Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,049 | -40,834 | -162,337 | -97,905 | -61,140 |
| Depreciation Amortization | -6,689 | -1,142 | -5,735 | -4,977 | -2,765 |
| Accounts receivable | -54 | -1,178 | 755 | -4,193 | 768 |
| Accounts payable and accrued liabilities | 3,215 | 6,999 | 11,277 | 4,593 | 1,589 |
| Other Working Capital | -2,796 | 2,216 | 16,726 | 4,244 | 1,389 |
| Other Operating Activity | 19,536 | 5,083 | 10,254 | 16,161 | 8,637 |
| Operating Cash Flow | $-77,837 | $-28,856 | $-129,060 | $-82,077 | $-51,522 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -612,299 | 104,625 | -122,620 | -159,961 | 41,309 |
| PPE Investments | -191 | -10 | -213 | -75 | -70 |
| Purchase Of Investment | N/A | -238,588 | N/A | N/A | N/A |
| Investing Cash Flow | $-612,490 | $-133,973 | $-122,833 | $-160,036 | $41,239 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 751,333 | 740,752 | 280,488 | 275,413 | 728 |
| Other Financing Activity | -1,543 | -1,342 | -363 | -171 | 1 |
| Financing Cash Flow | $749,790 | $739,410 | $280,125 | $275,242 | $729 |
| Beginning Cash Position | 51,254 | 51,254 | 23,022 | 23,022 | 23,022 |
| End Cash Position | 110,717 | 627,835 | 51,254 | 56,151 | 13,468 |
| Net Cash Flow | $59,463 | $576,581 | $28,232 | $33,129 | $-9,554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,837 | -28,856 | -129,060 | -82,077 | -51,522 |
| Capital Expenditure | -191 | -10 | -213 | -75 | -70 |
| Free Cash Flow | -78,028 | -28,866 | -129,273 | -82,152 | -51,592 |